Home > Education & Research > Research

Overview

The Fourth Affiliated Hospital of Zhejiang University (ZJU4H)is committed to building a disease-centered clinical research and innovation system, with a focus on fostering regionally top-tier and internationally leading disciplines such as oncology, reproductive medicine and geroscience. Concentrating on cutting-edge fields including stem-cell therapy for chronic diseases, immunotherapy for drug-resistant lung cancer, biological therapy for gastrointestinal tumors, and "AI-empowered personalized medicine", it drives the translation of research achievements from the laboratory to clinical practice.
Learn More
Research Centers
Clinical Trials

The world's first mRNA-interleukin-2 preparation has completed Phase I clinical trial

Led by Professor Wang Kai, the world's first mRNA-interleukin-2 preparation has completed Phase I clinical trial. It passed the review by the US FDA in November 2025 and advanced into Phase II clinical stage, with an international multi-center collaborative study launched in partnership with Massachusetts General Hospital.
Learn More
  • : N1 Shangcheng Avenue, Yiwu City, Zhejiang Province
  • : +86 0579-89979999
©2020 Copyright The fourth affiliated hospital ZheJiang universty shool of medicine All Rights Reserved